Late last month, President Donald Trump issued letters to Lilly CEO David Ricks and to the CEOs of roughly a dozen other large pharmaceutical companies, giving them until late September to cut the U.S. prices of certain drugs or the administration will “deploy every tool in our arsenal to protect American families.”

Pharma giant Eli Lilly said it is negotiating to raise drug prices in Europe, starting in the U.K. with the weight-loss drug Mounjaro, so that it can comply with the Trump administration’s goal of bringing down prices in the U.S.

As President Donald Trump works to move sky-high U.S. drug prices closer to those in other developed countries, Eli Lilly seems willing to play ball. | Eli Lilly said it has "intensified efforts to align prices across developed countries" in recent months.